State Street Corp Buys 114,085 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

State Street Corp boosted its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 0.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,339,753 shares of the real estate investment trust's stock after acquiring an additional 114,085 shares during the period. State Street Corp owned 4.57% of Omega Healthcare Investors worth $502,228,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cetera Investment Advisers lifted its holdings in Omega Healthcare Investors by 170.6% in the first quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust's stock valued at $3,099,000 after buying an additional 61,700 shares during the period. Cetera Advisors LLC bought a new position in shares of Omega Healthcare Investors in the 1st quarter worth $646,000. CWM LLC boosted its position in shares of Omega Healthcare Investors by 12.1% in the 2nd quarter. CWM LLC now owns 4,073 shares of the real estate investment trust's stock worth $140,000 after purchasing an additional 440 shares during the last quarter. Simplicity Wealth LLC acquired a new stake in shares of Omega Healthcare Investors during the second quarter worth $204,000. Finally, QRG Capital Management Inc. increased its holdings in Omega Healthcare Investors by 2.1% in the second quarter. QRG Capital Management Inc. now owns 60,806 shares of the real estate investment trust's stock valued at $2,083,000 after purchasing an additional 1,274 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI remained flat at $39.25 during mid-day trading on Monday. The company had a trading volume of 1,531,578 shares, compared to its average volume of 1,683,968. The business's 50 day moving average price is $40.48 and its 200 day moving average price is $37.69. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $10.60 billion, a P/E ratio of 28.86, a P/E/G ratio of 1.22 and a beta of 0.98. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.83%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Wells Fargo & Company restated an "overweight" rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price for the company in a research note on Monday. Royal Bank of Canada increased their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. Scotiabank boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Finally, Truist Financial raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research note on Wednesday, September 4th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $40.18.

Insider Activity at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.